Purpose: This study aimed to evaluate the efficacy of dynamical neurofeedback therapy as a nonpharmacological
intervention for managing Attention Deficit Hyperactivity Disorder (ADHD) and
anxiety disorders through comprehensive analysis of clinical outcomes.
Design/Methodology/Approach: A retrospective analysis was conducted on 113 clinical cases (68
ADHD, 45 anxiety) who completed dynamical neurofeedback therapy using the NeurOptimal system
between January-September 2025. Pre- and post-treatment assessments included standardized symptom
ratings and qualitative data. Outcomes were compared across diagnostic groups.
Findings: Significant improvements were observed across all parameters: anxiety scores reduced
from 7.2±1.4 to 5.0±1.2 (p<0.01), and attention scores improved from 5.8±1.2 to 7.2±1.0 (p<0.05).
Both ADHD and anxiety groups showed comparable overall response rates, though anxiety symptoms
showed earlier improvement than ADHD symptoms.
Conclusion: Dynamical neurofeedback demonstrates promising efficacy for managing ADHD and
anxiety with moderate to large effect sizes comparable to conventional treatments.
Practical Implications: Findings support the clinical implementation of dynamical neurofeedback as a
non-invasive intervention, particularly valuable for individuals with medication contraindications or
preference for non-pharmacological approaches.
